Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0213 Transporter Info | ||||
Gene Name | SLC25A5 | ||||
Transporter Name | Adenine nucleotide translocator 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview ofSLC25A5 Modification Sites with Functional and Structural Information | |||||
Sequence | MTDAAVSFAK DFLAGGVAAA ISKTAVAPIE RVKLLLQVQH ASKQITADKQ YKGIIDCVVR
IPKEQGVLSF WRGNLANVIR YFPTQALNFA FKDKYKQIFL GGVDKRTQFW LYFAGNLASG GAAGATSLCF VYPLDFARTR LAADVGKAGA EREFRGLGDC LVKIYKSDGI KGLYQGFNVS VQGIIIYRAA YFGIYDTAKG MLPDPKNTHI VISWMIAQTV TAVAGLTSYP FDTVRRRMMM QSGRKGTDIM YTGTLDCWRK IARDEGGKAF FKGAWSNVLR GMGGAFVLVL YDEIKKYT |
||||
PTM type |
X-Acetylation
X-Glutathionylation
X-Malonylation
X-Methylation
X-Oxidation
X-Phosphorylation
X-Phosphorylation
X-S-glutathionylation
X-S-nitrosylation
X-S-palmitoylation
X-S-sulfhydration
X-Succinylation
X-Sulfoxidation
X-SUMOylation
X-Ubiquitination
X: Amino Acid
|
Acetylation |
|||||
---|---|---|---|---|---|
Lysine | 17 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [1], [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
10 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 10 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [1], [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
23 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 23 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [4], [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
33 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 33 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [1], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
43 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 43 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
52 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 52 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [2], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
63 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 63 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A5 | [1], [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
92 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 92 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence SLC25A5 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
94 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 94 has the potential to affect its expression or activity. | ||||
PTM Phenomenon9 |
Have the potential to influence SLC25A5 | [1], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
96 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 96 has the potential to affect its expression or activity. | ||||
PTM Phenomenon10 |
Have the potential to influence SLC25A5 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
105 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 105 has the potential to affect its expression or activity. | ||||
PTM Phenomenon11 |
Have the potential to influence SLC25A5 | [1], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
147 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 147 has the potential to affect its expression or activity. | ||||
PTM Phenomenon12 |
Have the potential to influence SLC25A5 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
163 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 163 has the potential to affect its expression or activity. | ||||
PTM Phenomenon13 |
Have the potential to influence SLC25A5 | [1], [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
166 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 166 has the potential to affect its expression or activity. | ||||
PTM Phenomenon14 |
Have the potential to influence SLC25A5 | [1], [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
199 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 199 has the potential to affect its expression or activity. | ||||
PTM Phenomenon15 |
Have the potential to influence SLC25A5 | [1], [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
268 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 268 has the potential to affect its expression or activity. | ||||
PTM Phenomenon16 |
Have the potential to influence SLC25A5 | [1], [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
272 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 272 has the potential to affect its expression or activity. | ||||
PTM Phenomenon17 |
Have the potential to influence SLC25A5 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
295 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Lysine 295 has the potential to affect its expression or activity. | ||||
Methionine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
1 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Methionine 1 has the potential to affect its expression or activity. | ||||
Threonine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [11], [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A5 Threonine 2 has the potential to affect its expression or activity. | ||||
Glutathionylation |
|||||
Cystine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
257 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Glutathionylation at SLC25A5 Cystine 257 has the potential to affect its expression or activity. | ||||
Malonylation |
|||||
Lysine | 8 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [14], [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
23 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 23 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [14] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
33 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 33 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [14], [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
92 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 92 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [14], [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
96 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 96 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [14] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
105 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 105 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [14], [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
147 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 147 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A5 | [14] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
163 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 163 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence SLC25A5 | [14] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
272 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Malonylation at SLC25A5 Lysine 272 has the potential to affect its expression or activity. | ||||
Methylation |
|||||
Arginine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [16] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Arginine |
Modified Location |
155 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Arginine 155 has the potential to affect its expression or activity. | ||||
Lysine | 6 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [17] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
10 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Lysine 10 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [18] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
43 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Lysine 43 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [19] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
52 | ||
Related Enzyme |
|||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Lysine 52 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [20] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
147 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Lysine 147 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [21] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
166 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Lysine 166 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [8], [22] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
272 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A5 Lysine 272 has the potential to affect its expression or activity. | ||||
Oxidation |
|||||
Cystine | 3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [23], [24] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
57 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A5 Cystine 57 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [23], [24] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
129 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A5 Cystine 129 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [23], [24] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
257 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A5 Cystine 257 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine | 9 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [25], [26] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
7 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 7 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [27], [28] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
22 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 22 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [28], [29] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
42 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 42 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [27], [30] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
69 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 69 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [31], [32] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
119 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 119 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [27], [33] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
127 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 127 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A5 | [34] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
167 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 167 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence SLC25A5 | [35] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
242 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 242 has the potential to affect its expression or activity. | ||||
PTM Phenomenon9 |
Have the potential to influence SLC25A5 | [27], [36] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
276 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Serine 276 has the potential to affect its expression or activity. | ||||
Threonine | 9 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
. | [37] | |||
Role of PTM |
Influencing the Disease Progression | ||||
Modified Residue |
Threonine |
Modified Location |
107 | ||
Experimental Material(s) |
prostate cancer tissue | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 107 have been reported to inhibit the apoptosis of prostate cancer cells. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [38], [39] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 2 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [40], [41] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
24 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 24 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [27], [30] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
84 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 84 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [27], [33] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
126 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 126 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [40], [42] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
139 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 139 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A5 | [27], [43] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
197 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 197 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence SLC25A5 | [27], [44] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
247 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 247 has the potential to affect its expression or activity. | ||||
PTM Phenomenon9 |
Have the potential to influence SLC25A5 | [44] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
254 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Threonine 254 has the potential to affect its expression or activity. | ||||
Tyrosine | 7 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [45] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
51 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 51 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [27], [46] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
81 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 81 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [25], [27] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
112 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 112 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [34], [45] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
165 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 165 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [27], [47] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
191 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 191 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [27], [45] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
195 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 195 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A5 | [45] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
251 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A5 Tyrosine 251 has the potential to affect its expression or activity. | ||||
S-glutathionylation |
|||||
Cystine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [48] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
257 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-glutathionylation (-SSG) at SLC25A5 Cystine 257 has the potential to affect its expression or activity. | ||||
S-nitrosylation |
|||||
Cysteine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [49] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cysteine | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation at SLC25A5 Cysteine has the potential to affect its expression or activity. | ||||
Cystine | 3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [49], [50] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
129 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A5 Cystine 129 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [49], [51] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
160 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A5 Cystine 160 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [50], [52] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
257 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A5 Cystine 257 has the potential to affect its expression or activity. | ||||
S-palmitoylation |
|||||
Cystine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [53] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
160 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-palmitoylation at SLC25A5 Cystine 160 has the potential to affect its expression or activity. | ||||
S-sulfhydration |
|||||
Cystine | 3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [54] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
57 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-sulfhydration (-SSH) at SLC25A5 Cystine 57 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [54], [55] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
160 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-sulfhydration (-SSH) at SLC25A5 Cystine 160 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [55] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
257 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-sulfhydration (-SSH) at SLC25A5 Cystine 257 has the potential to affect its expression or activity. | ||||
Succinylation |
|||||
Lysine | 2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [56] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
43 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Succinylation at SLC25A5 Lysine 43 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [56] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
268 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Succinylation at SLC25A5 Lysine 268 has the potential to affect its expression or activity. | ||||
Sulfoxidation |
|||||
Methionine | 3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [57], [58] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
1 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sulfoxidation at SLC25A5 Methionine 1 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [57] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
215 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sulfoxidation at SLC25A5 Methionine 215 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [57] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
282 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sulfoxidation at SLC25A5 Methionine 282 has the potential to affect its expression or activity. | ||||
SUMOylation |
|||||
Lysine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
199 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sumoylation at SLC25A5 Lysine 199 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Lysine | 16 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A5 | [59], [60] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
10 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 10 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
23 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 23 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A5 | [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
33 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 33 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A5 | [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
43 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 43 has the potential to affect its expression or activity. | ||||
PTM Phenomenon5 |
Have the potential to influence SLC25A5 | [59], [60] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
63 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 63 has the potential to affect its expression or activity. | ||||
PTM Phenomenon6 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
92 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 92 has the potential to affect its expression or activity. | ||||
PTM Phenomenon7 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
96 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 96 has the potential to affect its expression or activity. | ||||
PTM Phenomenon8 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
105 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 105 has the potential to affect its expression or activity. | ||||
PTM Phenomenon9 |
Have the potential to influence SLC25A5 | [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
147 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 147 has the potential to affect its expression or activity. | ||||
PTM Phenomenon10 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
163 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 163 has the potential to affect its expression or activity. | ||||
PTM Phenomenon11 |
Have the potential to influence SLC25A5 | [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
166 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 166 has the potential to affect its expression or activity. | ||||
PTM Phenomenon12 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
199 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 199 has the potential to affect its expression or activity. | ||||
PTM Phenomenon13 |
Have the potential to influence SLC25A5 | [61], [62] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
245 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 245 has the potential to affect its expression or activity. | ||||
PTM Phenomenon14 |
Have the potential to influence SLC25A5 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
268 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 268 has the potential to affect its expression or activity. | ||||
PTM Phenomenon15 |
Have the potential to influence SLC25A5 | [8], [61] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
272 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 272 has the potential to affect its expression or activity. | ||||
PTM Phenomenon16 |
Have the potential to influence SLC25A5 | [59], [60] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
295 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A5 Lysine 295 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.